Biocon Announces $5.5 Billion Biologics Merger

In a transaction worth $5.5 billion, Biocon Ltd. will incorporate Biocon Biologics Ltd. as a fully owned subsidiary, the firm said on Saturday. Through a share exchange of 70.28 Biocon shares for every 100 Biocon Biologics shares, at ₹405.78 per share, Biocon will purchase the remaining shareholding in Biocon Biologics from Serum Institute Life Sciences, … Read more

IndiGo Cancels 1,000+ Flights Amid Operational Reboot

Following the widespread cancellation of IndiGo flights that left hundreds of customers stranded, the Ministry of Civil Aviation stated in a statement that the Government of India has decided to launch a high-level investigation into the disruption. As pilot rostering problems continued to cause widespread flight cancellations—more than 400 on Friday, December 5, 2025—the operations … Read more

Bitcoin Falls to $90K Ahead of PCE Data and Fed Speculation

Bitcoin Stabilizes at $70K as Markets Recover From Iran War Shock

As traders continued to concentrate on prospects of a U.S. Federal Reserve rate decrease and anticipated important inflation data, Bitcoin saw a decline on Friday but retained the majority of its gains following a strong midweek comeback. By 09:02 ET (14:02 GMT), the biggest cryptocurrency in the world has dropped 1.4% to $90,639. Earlier this … Read more

Ginkgo Bioworks Wins $47M DOE Contract, Shares Jump

The Environmental Molecular Sciences Laboratory at Pacific Northwest National Laboratory granted Ginkgo Bioworks Holdings (NYSE:DNA) a contract worth up to $47 million, which caused the company’s shares to rise 4.5% in premarket trade on Friday. In order to support the Department of Energy’s Microbial Molecular Phenotyping Capability, the four-year contract entails co-designing, constructing, and integrating … Read more